NGF/TNF-superfamily

Industry

CPC
C07K14/70575

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/70575NGF/TNF-superfamily

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Systems and methods for treating hyper-igm syndrome
- Patent number 12,214,055
- Issue date Feb 4, 2025
- Cecillia Cotta-Ramusino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Allograft tolerance without the need for systemic immune suppression
- Patent number 12,178,835
- Issue date Dec 31, 2024
- Sinai Health System
- Andras Nagy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ATP-dependent agonists of immune cells function as anticancer agents
- Patent number 12,180,297
- Issue date Dec 31, 2024
- Crosslink Therapeutics Inc.
- Rodolfo J. Chaparro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TNFR2 agonists with improved stability
- Patent number 12,173,046
- Issue date Dec 24, 2024
- Universitat Stuttgart
- Roman Fischer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cells expressing a chimeric antigen receptor
- Patent number 12,161,668
- Issue date Dec 10, 2024
- The General Hospital Corporation
- Marcela V. Maus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric antigen receptor and methods of use thereof
- Patent number 12,161,672
- Issue date Dec 10, 2024
- The Regents of the University of California
- Chia-Yung Wu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Enhanced antigen presenting ability of RNA car T cells by co-introd...
- Patent number 12,162,922
- Issue date Dec 10, 2024
- Novartis AG
- Yangbing Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of renal cell carcinoma
- Patent number 12,152,075
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Jason Samuel Simon
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Anti-PTK7 immune cell cancer therapy
- Patent number 12,146,157
- Issue date Nov 19, 2024
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunostimulating vector system
- Patent number 12,133,898
- Issue date Nov 5, 2024
- Provecs Medical GmbH
- Frank Schnieders
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Production of proteins in glutamine-free cell culture media
- Patent number 12,103,975
- Issue date Oct 1, 2024
- Genentech, Inc.
- Martin Gawlitzek
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Induction and enhancement of antitumor immunity involving Sindbis v...
- Patent number 12,097,257
- Issue date Sep 24, 2024
- New York University
- Daniel Meruelo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HLA-F-modified cells and methods
- Patent number 12,076,346
- Issue date Sep 3, 2024
- APPLIED STEMCELL, INC.
- Ruby Yanru Tsai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
HER2-targeting antigen binding molecules comprising 4-1BBL
- Patent number 12,065,478
- Issue date Aug 20, 2024
- HOFFMANN-LA ROCHE INC.
- Claudia Ferrara Koller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mouse having a humanized B-cell activating factor gene
- Patent number 12,058,987
- Issue date Aug 13, 2024
- REGENERON PHARMACEUTICALS, INC.
- John McWhirter
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Methods of use of anti-TNFα antibodies
- Patent number 12,055,549
- Issue date Aug 6, 2024
- UCB Biopharma SRL
- James Philip O'Connell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Exosomes for immuno-oncology and anti-inflammatory therapy
- Patent number 12,030,924
- Issue date Jul 9, 2024
- LONZA SALES AG
- Nuruddeen D. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Targeting B cell activating factor receptor (BAFF-R) using ligand-b...
- Patent number 12,023,354
- Issue date Jul 2, 2024
- Case Western Reserve University
- Reshmi Parameswaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Manipulated immunoregulatory element and immunity altered thereby
- Patent number 12,012,598
- Issue date Jun 18, 2024
- TOOLGEN INCORPORATED
- Seok Joong Kim
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Compositions and methods for selective protein degradation
- Patent number 11,999,802
- Issue date Jun 4, 2024
- Novartis AG
- James E. Bradner
- G01 - MEASURING TESTING
Information Patent Grant
Prostate-specific membrane antigen cars and methods of use thereof
- Patent number 11,992,503
- Issue date May 28, 2024
- The Trustees of the University of Pennsylvania
- Yangbing Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modified TNF as a capture ligand
- Patent number 11,957,825
- Issue date Apr 16, 2024
- IMMUNICOM INC.
- Michael Matho
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Mesothelin-targeted trail trimer
- Patent number 11,952,410
- Issue date Apr 9, 2024
- Washington University
- Dirk M. Spitzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion protein containing trail and IgG binding domain and the uses...
- Patent number 11,952,402
- Issue date Apr 9, 2024
- West China Hospital, Sichuan University
- Xiaofeng Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dimerizing agent regulated immunoreceptor complexes comprising inte...
- Patent number 11,952,413
- Issue date Apr 9, 2024
- 2seventy bio, Inc.
- Wai-Hang Leung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Materials and methods of using engineered ligands
- Patent number 11,952,411
- Issue date Apr 9, 2024
- Janssen Biotech, Inc.
- Adam Zwolak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer fusion polypeptide capable of binding both CD137 and gl...
- Patent number 11,919,931
- Issue date Mar 5, 2024
- Pieris Pharmaceuticals GmbH
- Marlon Hinner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound chimeric antigen receptor (cCAR) targeting multiple antige...
- Patent number 11,905,528
- Issue date Feb 20, 2024
- iCell Gene Therapeutics Inc.
- Yupo Ma
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-epidermal growth factor receptor variant III chimeric antigen...
- Patent number 11,879,017
- Issue date Jan 23, 2024
- The United States of America, as represented by the Secretary, Department of...
- Richard A Morgan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding chimeric receptor comprising NKP30 receptor...
- Patent number 11,872,248
- Issue date Jan 16, 2024
- The Trustees of Dartmouth College
- Tong Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
ANTI-PTK7 IMMUNE CELL CANCER THERAPY
- Publication number 20250074965
- Publication date Mar 6, 2025
- CRISPR Therapeutics AG
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA
- Publication number 20250066493
- Publication date Feb 27, 2025
- Genentech, Inc.
- Martin GAWLITZEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL
- Publication number 20250066448
- Publication date Feb 27, 2025
- HOFFMANN-LA ROCHE INC.
- Claudia FERRARA KOLLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells
- Publication number 20250057884
- Publication date Feb 20, 2025
- Beijing Solobio Genetechnology Co., Ltd.
- Weijun ZHU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF TREATING AN AUTOIMMUNE DISEASE BY ADMINISTERING AN ANTI-H...
- Publication number 20250060370
- Publication date Feb 20, 2025
- Kowa Company, Ltd.
- Tsutomu Takeuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD27 AGONISTS
- Publication number 20250059291
- Publication date Feb 20, 2025
- CELLDEX THERAPEUTICS, INC.
- Tibor KELER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RNA CONSTRUCT
- Publication number 20250051798
- Publication date Feb 13, 2025
- Imperial College Innovations Limited
- Paul McKay
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ENGINEERED CELLS
- Publication number 20250041336
- Publication date Feb 6, 2025
- VITA THERAPEUTICS, INC.
- Aihong ZHANG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
- Publication number 20250025540
- Publication date Jan 23, 2025
- University of Pittsburgh of the Commonwealth System of Higher Education
- JAY K. KOLLS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MECHANISM OF ACTION
- Publication number 20250012807
- Publication date Jan 9, 2025
- UCB Biopharma SRL
- James Philip O'CONNELL
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES A...
- Publication number 20250009772
- Publication date Jan 9, 2025
- The Johns Hopkins University
- Atul Bedi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGE...
- Publication number 20250002550
- Publication date Jan 2, 2025
- iCell Gene Therapeutics Inc.
- Yupo MA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY I...
- Publication number 20250001015
- Publication date Jan 2, 2025
- University of Massachusetts
- Ann Marshak-Rothstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES
- Publication number 20240409608
- Publication date Dec 12, 2024
- NAVICURE BIOPHARMACEUTICALS LIMITED
- Chia-Mao WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF
- Publication number 20240409654
- Publication date Dec 12, 2024
- LEGEND BIOTECH USA INC.
- Xiaohu FAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CELLS EXPRESSING FAS LIGAND AND CFLIP POLYPEPTIDES AND USES THEREOF
- Publication number 20240398866
- Publication date Dec 5, 2024
- Memorial Sloan-Kettering Cancer Center
- Prasad S. ADUSUMILLI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY
- Publication number 20240392011
- Publication date Nov 28, 2024
- University of Southern California
- Alan L. Epstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION
- Publication number 20240384007
- Publication date Nov 21, 2024
- Novartis AG
- James E. Bradner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Cells Expressing FAS Ligand Polypeptides and FAS Knockout and Uses...
- Publication number 20240350547
- Publication date Oct 24, 2024
- Memorial Sloan-Kettering Cancer Center
- Michel Sadelain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE
- Publication number 20240341291
- Publication date Oct 17, 2024
- Regeneron Pharmaceuticals, Inc.
- John MCWHIRTER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELLS EXPRESSING SAME
- Publication number 20240335538
- Publication date Oct 10, 2024
- Korea Research Institute of Bioscience and Biotechnology
- Tae-Don KIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-B...
- Publication number 20240299451
- Publication date Sep 12, 2024
- Case Western Reserve University
- Reshmi Parameswaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY
- Publication number 20240301424
- Publication date Sep 12, 2024
- Toolgen Incorporated
- Seok Joong Kim
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND...
- Publication number 20240293454
- Publication date Sep 5, 2024
- GUANGZHOU FINELMMUNE BIOTECHNOLOGY CO., LTD.
- Haiping LIU
- G01 - MEASURING TESTING
Information Patent Application
DARIC INTERLEUKIN RECEPTORS
- Publication number 20240287157
- Publication date Aug 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Wai-Hang Leung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF DEATH LIGANDS ON HEMATOPOIETIC STEM AND PROGENITOR CELLS AND...
- Publication number 20240285692
- Publication date Aug 29, 2024
- COCYTUS LTD.
- Nadir ASKENASY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY
- Publication number 20240279336
- Publication date Aug 22, 2024
- Nantes Université
- Nicolas BOISGERAULT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT CD40 BINDING PROTEINS AND THEIR USE
- Publication number 20240279309
- Publication date Aug 22, 2024
- Molecular Partners AG
- Valérie Perrine CALABRO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...
- Publication number 20240271090
- Publication date Aug 15, 2024
- The Trustees of the University of Pennsylvania
- Marco RUELLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents
- Publication number 20240254254
- Publication date Aug 1, 2024
- Crosslink Therapeutics Inc.
- Rodolfo J. CHAPARRO
- C07 - ORGANIC CHEMISTRY

NGF/TNF-superfamily

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Systems and methods for treating hyper-igm syndrome

Allograft tolerance without the need for systemic immune suppression

ATP-dependent agonists of immune cells function as anticancer agents

TNFR2 agonists with improved stability

T cells expressing a chimeric antigen receptor

Chimeric antigen receptor and methods of use thereof

Enhanced antigen presenting ability of RNA car T cells by co-introd...

Treatment of renal cell carcinoma

Anti-PTK7 immune cell cancer therapy

Immunostimulating vector system

Production of proteins in glutamine-free cell culture media

Induction and enhancement of antitumor immunity involving Sindbis v...

HLA-F-modified cells and methods

HER2-targeting antigen binding molecules comprising 4-1BBL

Mouse having a humanized B-cell activating factor gene

Methods of use of anti-TNFα antibodies

Exosomes for immuno-oncology and anti-inflammatory therapy

Targeting B cell activating factor receptor (BAFF-R) using ligand-b...

Manipulated immunoregulatory element and immunity altered thereby

Compositions and methods for selective protein degradation

Prostate-specific membrane antigen cars and methods of use thereof

Modified TNF as a capture ligand

Mesothelin-targeted trail trimer

Fusion protein containing trail and IgG binding domain and the uses...

Dimerizing agent regulated immunoreceptor complexes comprising inte...

Materials and methods of using engineered ligands

Anti-cancer fusion polypeptide capable of binding both CD137 and gl...

Compound chimeric antigen receptor (cCAR) targeting multiple antige...

Anti-epidermal growth factor receptor variant III chimeric antigen...

Nucleic acids encoding chimeric receptor comprising NKP30 receptor...

Patents Applicationslast 30 patents

ANTI-PTK7 IMMUNE CELL CANCER THERAPY

PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIA

HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL

Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells

METHOD OF TREATING AN AUTOIMMUNE DISEASE BY ADMINISTERING AN ANTI-H...

CD27 AGONISTS

RNA CONSTRUCT

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ENGINEERED CELLS

KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS

MECHANISM OF ACTION

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES A...

COMPOUND CHIMERIC ANTIGEN RECEPTOR (CCAR) TARGETING MULTIPLE ANTIGE...

AAV2-MEDIATED GENE DELIVERY OF SFASL AS A NEUROPROTECTIVE THERAPY I...

COMBINATION THERAPIES AGAINST CANCER AND INFECTIOUS DISEASES

CHIMERIC ANTIGEN RECEPTORS TARGETING BCMA AND METHODS OF USE THEREOF

CELLS EXPRESSING FAS LIGAND AND CFLIP POLYPEPTIDES AND USES THEREOF

HLA-G AS A NOVEL TARGET FOR CAR T-CELL IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

Cells Expressing FAS Ligand Polypeptides and FAS Knockout and Uses...

NON-HUMAN ANIMALS HAVING A HUMANIZED B-CELL ACTIVATING FACTOR GENE

NOVEL CHIMERIC ANTIGEN RECEPTOR AND IMMUNE CELLS EXPRESSING SAME

TARGETING B CELL ACTIVATING FACTOR RECEPTOR (BAFF-R) USING LIGAND-B...

MANIPULATED IMMUNOREGULATORY ELEMENT AND IMMUNITY ALTERED THEREBY

TCR-T CELL FOR KILLING TUMORS, AND PREPARATION METHOD THEREFOR AND...

DARIC INTERLEUKIN RECEPTORS

USE OF DEATH LIGANDS ON HEMATOPOIETIC STEM AND PROGENITOR CELLS AND...

CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY

RECOMBINANT CD40 BINDING PROTEINS AND THEIR USE

CRISPR-Cas9 Knock-out of SHP-1/2 to Reduce T cell Exhaustion in Ado...

ATP-Dependent Agonists of Immune Cells Function as Anticancer Agents